...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: One more horse in this race.

Abemaciclib = ELI LILLY!

 

YES!!!

 

One more contender to liven things up!

Share
New Message
Please login to post a reply